$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV 원문보기

Antiviral research, v.137, 2017년, pp.82 - 92  

Liu, W.J. ,  Zhao, M. ,  Liu, K. ,  Xu, K. ,  Wong, G. ,  Tan, W. ,  Gao, G.F.

Abstract AI-Helper 아이콘AI-Helper

Over 12 years have elapsed since severe acute respiratory syndrome (SARS) triggered the first global alert for coronavirus infections. Virus transmission in humans was quickly halted by public health measures and human infections of SARS coronavirus (SARS-CoV) have not been observed since. However, ...

주제어

참고문헌 (126)

  1. Agnihothram S. Gopal R. Yount B.L. Jr. Donaldson E.F. Menachery V.D. Graham R.L. Scobey T.D. Gralinski L.E. Denison M.R. Zambon M. Baric R.S. Evaluation of serologic and antigenic relationships between Middle Eastern respiratory syndrome coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronaviruses J.?Infect. Dis. 209 2014 995 1006 24253287 

  2. Akbari O. Panjwani N. Garcia S. Tascon R. Lowrie D. Stockinger B. DNA vaccination: transfection and activation of dendritic cells as key events for immunity J.?Exp. Med. 189 1999 169 178 9874573 

  3. Al-Abdallat M.M. Payne D.C. Alqasrawi S. Rha B. Tohme R.A. Abedi G.R. Al Nsour M. Iblan I. Jarour N. Farag N.H. Haddadin A. Al-Sanouri T. Tamin A. Harcourt J.L. Kuhar D.T. Swerdlow D.L. Erdman D.D. Pallansch M.A. Haynes L.M. Gerber S.I. Jordan M.-C.I.T. Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description Clin. Infect. Dis. 59 2014 1225 1233 24829216 

  4. Alshukairi A.N. Khalid I. Ahmed W.A. Dada A.M. Bayumi D.T. Malic L.S. Althawadi S. Ignacio K. Alsalmi H.S. Al-Abdely H.M. Wali G.Y. Qushmaq I.A. Alraddadi B.M. Perlman S. Antibody response and disease severity in healthcare worker MERS survivors Emerg. Infect. Dis. 22 6 2016 

  5. Arabi Y.M. Hajeer A.H. Luke T. Raviprakash K. Balkhy H. Johani S. Al-Dawood A. Al-Qahtani S. Al-Omari A. Al-Hameed F. Hayden F.G. Fowler R. Bouchama A. Shindo N. Al-Khairy K. Carson G. Taha Y. Sadat M. Alahmadi M. Feasibility of using convalescent plasma immunotherapy for MERS-CoV infection, Saudi Arabia Emerg. Infect. Dis. 22 2016 1554 1561 27532807 

  6. Blicher T. Kastrup J.S. Buus S. Gajhede M. High-resolution structure of HLA-A*1101 in complex with SARS nucleocapsid peptide Acta Crystallogr. D. Biol. Crystallogr. 61 2005 1031 1040 16041067 

  7. Cameron M.J. Ran L. Xu L. Danesh A. Bermejo-Martin J.F. Cameron C.M. Muller M.P. Gold W.L. Richardson S.E. Poutanen S.M. Willey B.M. DeVries M.E. Fang Y. Seneviratne C. Bosinger S.E. Persad D. Wilkinson P. Greller L.D. Somogyi R. Humar A. Keshavjee S. Louie M. Loeb M.B. Brunton J. McGeer A.J. Canadian S.R.N. Kelvin D.J. Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome J.?Virol. 81 2007 8692 8706 17537853 

  8. Chan K.H. Chan J.F. Tse H. Chen H. Lau C.C. Cai J.P. Tsang A.K. Xiao X. To K.K. Lau S.K. Woo P.C. Zheng B.J. Wang M. Yuen K.Y. Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests J.?Infect. Dis. 67 2013 130 140 

  9. Channappanavar R. Fehr A.R. Vijay R. Mack M. Zhao J. Meyerholz D.K. Perlman S. Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice Cell Host Microbe 19 2016 181 193 26867177 

  10. Channappanavar R. Fett C. Zhao J. Meyerholz D.K. Perlman S. Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection J.?Virol. 88 2014 11034 11044 25056892 

  11. Chen H. Hou J. Jiang X. Ma S. Meng M. Wang B. Zhang M. Zhang M. Tang X. Zhang F. Wan T. Li N. Yu Y. Hu H. Yang R. He W. Wang X. Cao X. Response of memory CD8+ T cells to severe acute respiratory syndrome (SARS) coronavirus in recovered SARS patients and healthy individuals J.?Immunol. 175 2005 591 598 15972696 

  12. Chen J. Lau Y.F. Lamirande E.W. Paddock C.D. Bartlett J.H. Zaki S.R. Subbarao K. Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection J.?Virol. 84 2010 1289 1301 19906920 

  13. Chen X. Yang X. Zheng Y. Yang Y. Xing Y. Chen Z. SARS coronavirus papain-like protease inhibits the type I interferon signaling pathway through interaction with the STING-TRAF3-TBK1 complex Protein Cell 5 2014 369 381 24622840 

  14. Chen Y.Z. Liu G. Senju S. Wang Q. Irie A. Haruta M. Matsui M. Yasui F. Kohara M. Nishimura Y. Identification of SARS-COV spike protein-derived and HLA-A2-restricted human CTL epitopes by using a new muramyl dipeptidederivative adjuvant Int. J. Immunopathol. Pharmacol. 23 2010 165 177 20378004 

  15. Cheung Y.K. Cheng S.C. Sin F.W. Chan K.T. Xie Y. Induction of T-cell response by a DNA vaccine encoding a novel HLA-A*0201 severe acute respiratory syndrome coronavirus epitope Vaccine 25 2007 6070 6077 17629360 

  16. Chu H. Zhou J. Wong B.H. Li C. Chan J.F. Cheng Z.S. Yang D. Wang D. Lee A.C. Li C. Yeung M.L. Cai J.P. Chan I.H. Ho W.K. To K.K. Zheng B.J. Yao Y. Qin C. Yuen K.Y. Middle East respiratory syndrome coronavirus efficiently infects human primary T Lymphocytes and activates the extrinsic and intrinsic apoptosis pathways J.?Infect. Dis. 213 2016 904 914 26203058 

  17. Corman V.M. Albarrak A.M. Omrani A.S. Albarrak M.M. Farah M.E. Almasri M. Muth D. Sieberg A. Meyer B. Assiri A.M. Binger T. Steinhagen K. Lattwein E. Al-Tawfiq J. Muller M.A. Drosten C. Memish Z.A. Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection Clin. Infect. Dis. 62 2016 477 483 26565003 

  18. Corman V.M. Ithete N.L. Richards L.R. Schoeman M.C. Preiser W. Drosten C. Drexler J.F. Rooting the phylogenetic tree of Middle East respiratory syndrome coronavirus by characterization of a conspecific virus from an African bat J.?Virol. 88 2014 11297 11303 25031349 

  19. Corti D. Zhao J. Pedotti M. Simonelli L. Agnihothram S. Fett C. Fernandez-Rodriguez B. Foglierini M. Agatic G. Vanzetta F. Gopal R. Langrish C.J. Barrett N.A. Sallusto F. Baric R.S. Varani L. Zambon M. Perlman S. Lanzavecchia A. Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus Proc. Natl. Acad. Sci. U. S. A. 112 2015 10473 10478 26216974 

  20. Da Guan W. Mok C.K. Chen Z.L. Feng L.Q. Li Z.T. Huang J.C. Ke C.W. Deng X. Ling Y. Wu S.G. Niu X.F. Perera R.A. Da Xu Y. Zhao J. Zhang L.Q. Li Y.M. Chen R.C. Peiris M. Chen L. Zhong N.S. Characteristics of traveler with Middle East respiratory syndrome, China, 2015 Emerg. Infect. Dis. 21 2015 2278 2280 26583433 

  21. Doytchinova I. Flower D. The HLA-A2-supermotif: a QSAR definition Organ. Biomol. Chem. 1 2003 2648 2654 

  22. Du L. He Y. Zhou Y. Liu S. Zheng B.J. Jiang S. The spike protein of SARS-CoV?a target for vaccine and therapeutic development Nat. Rev. Microbiol. 7 2009 226 236 19198616 

  23. Du L. Ma C. Jiang S. Antibodies induced by receptor-binding domain in spike protein of SARS-CoV do not cross-neutralize the novel human coronavirus hCoV-EMC J.?Infect. 67 2013 348 350 23685240 

  24. Du L. Tai W. Zhou Y. Jiang S. Vaccines for the prevention against the threat of MERS-CoV Expert Rev. Vac. 15 2016 1123 1134 

  25. Du L. Zhao G. Chan C.C. Li L. He Y. Zhou Y. Zheng B.J. Jiang S. A?219-mer CHO-expressing receptor-binding domain of SARS-CoV S protein induces potent immune responses and protective immunity Viral Immunol. 23 2010 211 219 20374001 

  26. Du L. Zhao G. Li L. He Y. Zhou Y. Zheng B.J. Jiang S. Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably expressed in CHO cells Biochem. Biophys. Res. Commun. 384 2009 486 490 19422787 

  27. Du L. Zhao G. Lin Y. Sui H. Chan C. Ma S. He Y. Jiang S. Wu C. Yuen K.Y. Jin D.Y. Zhou Y. Zheng B.J. Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection J.?Immunol. 180 2008 948 956 18178835 

  28. Fan Y.Y. Huang Z.T. Li L. Wu M.H. Yu T. Koup R.A. Bailer R.T. Wu C.Y. Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection Arch. Virol. 154 2009 1093 1099 19526193 

  29. Faure E. Poissy J. Goffard A. Fournier C. Kipnis E. Titecat M. Bortolotti P. Martinez L. Dubucquoi S. Dessein R. Gosset P. Mathieu D. Guery B. Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside? PloS One 9 2014 e88716 24551142 

  30. Feng Y. Gao G.F. Towards our understanding of SARS-CoV, an emerging and devastating but quickly conquered virus Comp. Immunol. Microbiol. Infect. Dis. 30 2007 309 327 17640731 

  31. Frieman M.B. Chen J. Morrison T.E. Whitmore A. Funkhouser W. Ward J.M. Lamirande E.W. Roberts A. Heise M. Subbarao K. Baric R.S. SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism PLoS Pathog. 6 2010 e1000849 20386712 

  32. Gu J. Gong E. Zhang B. Zheng J. Gao Z. Zhong Y. Zou W. Zhan J. Wang S. Xie Z. Zhuang H. Wu B. Zhong H. Shao H. Fang W. Gao D. Pei F. Li X. He Z. Xu D. Shi X. Anderson V.M. Leong A.S. Multiple organ infection and the pathogenesis of SARS J.?Exp. Med. 202 2005 415 424 16043521 

  33. He Y. Zhou Y. Siddiqui P. Niu J. Jiang S. Identification of immunodominant epitopes on the membrane protein of the severe acute respiratory syndrome-associated coronavirus J.?Clin. Microbiol. 43 2005 3718 3726 16081901 

  34. Hijawi B. Abdallat M. Sayaydeh A. Alqasrawi S. Haddadin A. Jaarour N. Alsheikh S. Alsanouri T. Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation East Mediterr Health J 19 Suppl.?1 2013 S12 S18 23888790 

  35. Hilgenfeld R. Peiris M. From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses Antivir. Res. 100 2013 286 295 24012996 

  36. Hsueh P.R. Huang L.M. Chen P.J. Kao C.L. Yang P.C. Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus Clin. Microbiol. Infect. 10 2004 1062 1066 15606632 

  37. Huang J. Cao Y. Du J. Bu X. Ma R. Wu C. Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses Vaccine 25 2007 6981 6991 17709158 

  38. Huang M. Zhang W. Guo J. Wei X. Phiwpan K. Zhang J. Zhou X. Improved transgenic mouse model for studying HLA class I antigen presentation Sci. Rep. 6 2016 33612 27634283 

  39. Jauregui A.R. Savalia D. Lowry V.K. Farrell C.M. Wathelet M.G. Identification of residues of SARS-CoV nsp1 that differentially affect inhibition of gene expression and antiviral signaling PloS One 8 2013 e62416 23658627 

  40. Julien J.-P. Lee P.S. Wilson I.A. Structural insights into key sites of vulnerability on HIV-1 Env and influenza HA Immunol. Rev. 250 2012 180 198 23046130 

  41. Kapoor M. Pringle K. Kumar A. Dearth S. Liu L. Lovchik J. Perez O. Pontones P. Richards S. Yeadon-Fagbohun J. Breakwell L. Chea N. Cohen N.J. Schneider E. Erdman D. Haynes L. Pallansch M. Tao Y. Tong S. Gerber S. Swerdlow D. Feikin D.R. Clinical and laboratory findings of the first imported case of Middle East respiratory syndrome coronavirus to the United States Clin. Infect. Dis. 59 2014 1511 1518 25100864 

  42. Kohyama S. Ohno S. Suda T. Taneichi M. Yokoyama S. Mori M. Kobayashi A. Hayashi H. Uchida T. Matsui M. Efficient induction of cytotoxic T lymphocytes specific for severe acute respiratory syndrome (SARS)-associated coronavirus by immunization with surface-linked liposomal peptides derived from a non-structural polyprotein 1a Antivir. Res. 84 2009 168 177 19748524 

  43. Kopecky-Bromberg S.A. Martinez-Sobrido L. Frieman M. Baric R.A. Palese P. Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists J.?Virol. 81 2007 548 557 17108024 

  44. Ksiazek T.G. Erdman D. Goldsmith C.S. Zaki S.R. Peret T. Emery S. Tong S. Urbani C. Comer J.A. Lim W. Rollin P.E. Dowell S.F. Ling A.E. Humphrey C.D. Shieh W.J. Guarner J. Paddock C.D. Rota P. Fields B. DeRisi J. Yang J.Y. Cox N. Hughes J.M. LeDuc J.W. Bellini W.J. Anderson L.J. Group S.W. A?novel coronavirus associated with severe acute respiratory syndrome New Engl. J. Med. 348 2003 1953 1966 12690092 

  45. Kuba K. Imai Y. Rao S. Gao H. Guo F. Guan B. Huan Y. Yang P. Zhang Y. Deng W. Bao L. Zhang B. Liu G. Wang Z. Chappell M. Liu Y. Zheng D. Leibbrandt A. Wada T. Slutsky A.S. Liu D. Qin C. Jiang C. Penninger J.M. A?crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury Nat. Med. 11 2005 875 879 16007097 

  46. Lan J. Deng Y. Chen H. Lu G. Wang W. Guo X. Lu Z. Gao G.F. Tan W. Tailoring subunit vaccine immunity with adjuvant combinations and delivery routes using the Middle East respiratory coronavirus (MERS-CoV) receptor-binding domain as an antigen PloS One 9 2014 e112602 25405618 

  47. Lau S.K. Li K.S. Tsang A.K. Lam C.S. Ahmed S. Chen H. Chan K.H. Woo P.C. Yuen K.Y. Genetic characterization of Betacoronavirus lineage C viruses in bats reveals marked sequence divergence in the spike protein of pipistrellus bat coronavirus HKU5 in Japanese pipistrelle: implications for the origin of the novel Middle East respiratory syndrome coronavirus J.?Virol. 87 2013 8638 8650 23720729 

  48. Le Prevost C. Levy-Leblond E. Virelizier J.L. Dupuy J.M. Immunopathology of mouse hepatitis virus type 3 infection. Role of humoral and cell-mediated immunity in resistance mechanisms J.?Immunol. 114 1975 221 225 163277 

  49. Leung D.T. Tam F.C. Ma C.H. Chan P.K. Cheung J.L. Niu H. Tam J.S. Lim P.L. Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid J.?Infect. Dis. 190 2004 379 386 15216476 

  50. Li C.K. Wu H. Yan H. Ma S. Wang L. Zhang M. Tang X. Temperton N.J. Weiss R.A. Brenchley J.M. Douek D.C. Mongkolsapaya J. Tran B.H. Lin C.L. Screaton G.R. Hou J.L. McMichael A.J. Xu X.N. T?cell responses to whole SARS coronavirus in humans J.?Immunol. 181 2008 5490 5500 18832706 

  51. Li F. Li W. Farzan M. Harrison S.C. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor Science 309 2005 1864 1868 16166518 

  52. Li H. Wang Y. Han Z. Wang Y. Liang S. Jiang L. Hu Y. Kong X. Liu S. Recombinant duck enteritis viruses expressing major structural proteins of the infectious bronchitis virus provide protection against infectious bronchitis in chickens Antivir. Res. 130 2016 19 26 26946113 

  53. Li W. Shi Z. Yu M. Ren W. Smith C. Epstein J.H. Wang H. Crameri G. Hu Z. Zhang H. Zhang J. McEachern J. Field H. Daszak P. Eaton B.T. Zhang S. Wang L.F. Bats are natural reservoirs of SARS-like coronaviruses Science 310 2005 676 679 16195424 

  54. Li Y. Wan Y. Liu P. Zhao J. Lu G. Qi J. Wang Q. Lu X. Wu Y. Liu W. Zhang B. Yuen K.Y. Perlman S. Gao G.F. Yan J. A?humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein Cell Res. 25 2015 1237 1249 26391698 

  55. Lin Y. Shen X. Yang R.F. Li Y.X. Ji Y.Y. He Y.Y. Shi M.D. Lu W. Shi T.L. Wang J. Wang H.X. Jiang H.L. Shen J.H. Xie Y.H. Wang Y. Pei G. Shen B.F. Wu J.R. Sun B. Identification of an epitope of SARS-coronavirus nucleocapsid protein Cell Res. 13 2003 141 145 12862314 

  56. Liu J. Qi J. Gao F. Yan J. Gao G.F. Functional and structural definition of a clustering region of HLA-A2-restricted cytotoxic T lymphocyte epitopes Sci. Tech. Rev. China 29 2011 8 

  57. Liu J. Sun Y. Qi J. Chu F. Wu H. Gao F. Li T. Yan J. Gao G.F. The membrane protein of severe acute respiratory syndrome coronavirus acts as a dominant immunogen revealed by a clustering region of novel functionally and structurally defined cytotoxic T-lymphocyte epitopes J.?Infect. Dis. 202 2010 1171 1180 20831383 

  58. Liu J. Wu P. Gao F. Qi J. Kawana-Tachikawa A. Xie J. Vavricka C.J. Iwamoto A. Li T. Gao G.F. Novel immunodominant peptide presentation strategy: a featured HLA-A*2402-restricted cytotoxic T-lymphocyte epitope stabilized by intrachain hydrogen bonds from severe acute respiratory syndrome coronavirus nucleocapsid protein J.?Virol. 84 2010 11849 11857 20844028 

  59. Liu J. Zhang S. Tan S. Zheng B. Gao G.F. Revival of the identification of cytotoxic T-lymphocyte epitopes for immunological diagnosis, therapy and vaccine development Exp. Biol. Med. 236 2011 253 267 

  60. Liu P. Liu D. Yang X. Gao J. Chen Y. Xiao X. Liu F. Zou J. Wu J. Ma J. Zhao F. Zhou X. Gao G.F. Zhu B. Characterization of human alphabetaTCR repertoire and discovery of D-D fusion in TCRbeta chains Protein Cell 5 2014 603 615 24866699 

  61. Liu W. Fontanet A. Zhang P.H. Zhan L. Xin Z.T. Baril L. Tang F. Lv H. Cao W.C. Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome J.?Infect. Dis. 193 2006 792 795 16479513 

  62. Liu W.J. Lan J. Liu K. Deng Y. Yao Y. Wu S. Chen H. Bao L. Zhang H. Zhao M. Wang Q. Han L. Chai Y. Qi J. Zhao J. Meng S. Qin C. Gao G.F. Tan W. Protective T-cell responses featured by concordant recognition of MERS-CoV-derived CD8+ T-cell epitopes and host MHC J. Immunol. 2016 (in press) 

  63. Liu Y.V. Massare M.J. Barnard D.L. Kort T. Nathan M. Wang L. Smith G. Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV Vaccine 29 2011 6606 6613 21762752 

  64. Lokugamage K.G. Yoshikawa-Iwata N. Ito N. Watts D.M. Wyde P.R. Wang N. Newman P. Kent Tseng C.T. Peters C.J. Makino S. Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV Vaccine 26 2008 797 808 18191004 

  65. Lu G. Hu Y. Wang Q. Qi J. Gao F. Li Y. Zhang Y. Zhang W. Yuan Y. Bao J. Zhang B. Shi Y. Yan J. Gao G.F. Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26 Nature 500 2013 227 231 23831647 

  66. Lu G. Wang Q. Gao G.F. Bat-to-human: spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond Trends Microbiol. 23 2015 468 478 26206723 

  67. Lv Y. Ruan Z. Wang L. Ni B. Wu Y. Identification of a novel conserved HLA-A*0201-restricted epitope from the spike protein of SARS-CoV BMC Immunol. 10 2009 61 19958537 

  68. MacNamara K.C. Bender S.J. Chua M.M. Watson R. Weiss S.R. Priming of CD8+ T cells during central nervous system infection with a murine coronavirus is strain dependent J.?Virol. 82 2008 6150 6160 18417581 

  69. Martin J.E. Louder M.K. Holman L.A. Gordon I.J. Enama M.E. Larkin B.D. Andrews C.A. Vogel L. Koup R.A. Roederer M. Bailer R.T. Gomez P.L. Nason M. Mascola J.R. Nabel G.J. Graham B.S. Team V.R.C.S. A?SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial Vaccine 26 2008 6338 6343 18824060 

  70. Menachery V.D. Yount B.L. Jr. Josset L. Gralinski L.E. Scobey T. Agnihothram S. Katze M.G. Baric R.S. Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-o-methyltransferase activity J.?Virol. 88 2014 4251 4264 24478444 

  71. Meyer B. Drosten C. Muller M.A. Serological assays for emerging coronaviruses: challenges and pitfalls Virus Res. 194 2014 175 183 24670324 

  72. Min C.K. Cheon S. Ha N.Y. Sohn K.M. Kim Y. Aigerim A. Shin H.M. Choi J.Y. Inn K.S. Kim J.H. Moon J.Y. Choi M.S. Cho N.H. Kim Y.S. Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity Sci. Rep. 6 2016 25359 27146253 

  73. Morimoto C. Schlossman S.F. The structure and function of CD26 in the T-cell immune response Immunol. Rev. 161 1998 55 70 9553764 

  74. Ng O.W. Chia A. Tan A.T. Jadi R.S. Leong H.N. Bertoletti A. Tan Y.J. Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection Vaccine 34 2016 2008 2014 26954467 

  75. Niemeyer D. Zillinger T. Muth D. Zielecki F. Horvath G. Suliman T. Barchet W. Weber F. Drosten C. Muller M.A. Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist J.?Virol. 87 2013 12489 12495 24027320 

  76. Oh H.L. Chia A. Chang C.X. Leong H.N. Ling K.L. Grotenbreg G.M. Gehring A.J. Tan Y.J. Bertoletti A. Engineering T cells specific for a dominant severe acute respiratory syndrome coronavirus CD8 T cell epitope J.?Virol. 85 2011 10464 10471 21813600 

  77. Ohno S. Kohyama S. Taneichi M. Moriya O. Hayashi H. Oda H. Mori M. Kobayashi A. Akatsuka T. Uchida T. Matsui M. Synthetic peptides coupled to the surface of liposomes effectively induce SARS coronavirus-specific cytotoxic T lymphocytes and viral clearance in HLA-A*0201 transgenic mice Vaccine 27 2009 3912 3920 19490987 

  78. Park W.B. Perera R.A. Choe P.G. Lau E.H. Choi S.J. Chun J.Y. Oh H.S. Song K.H. Bang J.H. Kim E.S. Kim H.B. Park S.W. Kim N.J. Man Poon L.L. Peiris M. Oh M.D. Kinetics of serologic responses to MERS coronavirus infection in humans, South Korea Emerg. Infect. Dis. 21 2015 2186 2189 26583829 

  79. Peng H. Yang L.T. Wang L.Y. Li J. Huang J. Lu Z.Q. Koup R.A. Bailer R.T. Wu C.Y. Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients Virology 351 2006 466 475 16690096 

  80. Poh W.P. Narasaraju T. Pereira N.A. Zhong F. Phoon M.C. Macary P.A. Wong S.H. Lu J. Koh D.R. Chow V.T. Characterization of cytotoxic T-lymphocyte epitopes and immune responses to SARS coronavirus spike DNA vaccine expressing the RGD-integrin-binding motif J. Med. Virol. 81 2009 1131 1139 19475608 

  81. Raj V.S. Mou H. Smits S.L. Dekkers D.H. Muller M.A. Dijkman R. Muth D. Demmers J.A. Zaki A. Fouchier R.A. Thiel V. Drosten C. Rottier P.J. Osterhaus A.D. Bosch B.J. Haagmans B.L. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC Nature 495 2013 251 254 23486063 

  82. Reusken C. Mou H. Godeke G.J. van der Hoek L. Meyer B. Muller M.A. Haagmans B. de Sousa R. Schuurman N. Dittmer U. Rottier P. Osterhaus A. Drosten C. Bosch B.J. Koopmans M. Specific serology for emerging human coronaviruses by protein microarray Euro Surveil 18 2013 20441 

  83. Reusken C.B. Messadi L. Feyisa A. Ularamu H. Godeke G.J. Danmarwa A. Dawo F. Jemli M. Melaku S. Shamaki D. Woma Y. Wungak Y. Gebremedhin E.Z. Zutt I. Bosch B.J. Haagmans B.L. Koopmans M.P. Geographic distribution of MERS coronavirus among dromedary camels, Africa Emerg. Infect. Dis. 20 2014 1370 1374 25062254 

  84. Rivino L. Tan A.T. Chia A. Kumaran E.A. Grotenbreg G.M. MacAry P.A. Bertoletti A. Defining CD8+ T cell determinants during human viral infection in populations of Asian ethnicity J. Immunol. 191 2013 4010 4019 24058176 

  85. Roder G. Kristensen O. Kastrup J.S. Buus S. Gajhede M. Structure of a SARS coronavirus-derived peptide bound to the human major histocompatibility complex class I molecule HLA-B*1501 Acta Crystallogr. Sect. F. Struct. Biol. Cryst. Commun. 64 2008 459 462 

  86. Rota P.A. Oberste M.S. Monroe S.S. Nix W.A. Campagnoli R. Icenogle J.P. Penaranda S. Bankamp B. Maher K. Chen M.H. Tong S. Tamin A. Lowe L. Frace M. DeRisi J.L. Chen Q. Wang D. Erdman D.D. Peret T.C. Burns C. Ksiazek T.G. Rollin P.E. Sanchez A. Liffick S. Holloway B. Limor J. McCaustland K. Olsen-Rasmussen M. Fouchier R. Gunther S. Osterhaus A.D. Drosten C. Pallansch M.A. Anderson L.J. Bellini W.J. Characterization of a novel coronavirus associated with severe acute respiratory syndrome Science 300 2003 1394 1399 12730500 

  87. Sharpe H.J. Stevens T.J. Munro S. A?comprehensive comparison of transmembrane domains reveals organelle-specific properties Cell 142 2010 158 169 20603021 

  88. Stohlman S.A. Bergmann C.C. van der Veen R.C. Hinton D.R. Mouse hepatitis virus-specific cytotoxic T lymphocytes protect from lethal infection without eliminating virus from the central nervous system J.?Virol. 69 1995 684 694 7815531 

  89. Su S. Wong G. Liu Y. Gao G.F. Li S. Bi Y. MERS in South Korea and China: a potential outbreak threat? Lancet 385 2015 2349 2350 26088634 

  90. Su S. Wong G. Shi W. Liu J. Lai A.C. Zhou J. Liu W. Bi Y. Gao G.F. Epidemiology, genetic recombination, and pathogenesis of coronaviruses Trend Microbiol. 24 2016 490 502 

  91. Sun L. Zhang Y. Zhao B. Deng M. Liu J. Li X. Hou J. Gui M. Zhang S. Li X. Gao G.F. Meng S. A?new unconventional HLA-A2-restricted epitope from HBV core protein elicits antiviral cytotoxic T lymphocytes Protein Cell 5 2014 317 327 24659387 

  92. Takano T. Tomizawa K. Morioka H. Doki T. Hohdatsu T. Evaluation of protective efficacy of the synthetic peptide vaccine containing the T-helper 1 epitope with CpG oligodeoxynucleotide against feline infectious peritonitis virus infection in cats Antivir. Ther. 19 2014 645 650 24458025 

  93. Tang F. Quan Y. Xin Z.T. Wrammert J. Ma M.J. Lv H. Wang T.B. Yang H. Richardus J.H. Liu W. Cao W.C. Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study J.?Immunol. 186 2011 7264 7268 21576510 

  94. Tang X.C. Agnihothram S.S. Jiao Y. Stanhope J. Graham R.L. Peterson E.C. Avnir Y. Tallarico A.S. Sheehan J. Zhu Q. Baric R.S. Marasco W.A. Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution Proc. Natl. Acad. Sci. U. S. A. 111 2014 E2018 E2026 24778221 

  95. To K.K. Hung I.F. Chan J.F. Yuen K.Y. From SARS coronavirus to novel animal and human coronaviruses J.?Thorac. Dis. 5 2013 S103 S108 23977429 

  96. Trujillo J.A. Gras S. Twist K.A. Croft N.P. Channappanavar R. Rossjohn J. Purcell A.W. Perlman S. Structural and functional correlates of enhanced antiviral immunity generated by heteroclitic CD8 T cell epitopes J.?Immunol. 192 2014 5245 5256 24795457 

  97. Tsao Y.P. Lin J.Y. Jan J.T. Leng C.H. Chu C.C. Yang Y.C. Chen S.L. HLA-A*0201 T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus nucleocapsid and spike proteins Biochem. Biophys. Res. Commun. 344 2006 63 71 16630549 

  98. Tseng C.T. Sbrana E. Iwata-Yoshikawa N. Newman P.C. Garron T. Atmar R.L. Peters C.J. Couch R.B. Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus PloS One 7 2012 e35421 22536382 

  99. Vijay R. Perlman S. Middle East respiratory syndrome and severe acute respiratory syndrome Curr. Opin. Virol. 16 2016 70 76 26855039 

  100. Volz A. Kupke A. Song F. Jany S. Fux R. Shams-Eldin H. Schmidt J. Becker C. Eickmann M. Becker S. Sutter G. Protective efficacy of recombinant modified vaccinia virus ankara delivering Middle East respiratory syndrome coronavirus spike glycoprotein J.?Virol. 89 2015 8651 8656 26018172 

  101. Wang B.M. Chen H.B. Jiang X.D. Zhang M.H. Wan T. Li N. Zhou X.Y. Wu Y.F. Yang F. Yu Y.Z. Wang X.N. Yang R.F. Cao X.T. Identification of an HLA-A*0201-restricted CD8(+) T-cell epitope SSp-1 of SARS-CoV spike protein Blood 104 2004 200 206 15016646 

  102. Wang Q. Qi J. Yuan Y. Xuan Y. Han P. Wan Y. Ji W. Li Y. Wu Y. Wang J. Iwamoto A. Woo P.C. Yuen K.Y. Yan J. Lu G. Gao G.F. Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26 Cell Host Microbe 16 2014 328 337 25211075 

  103. Wang Q. Wong G. Lu G. Yan J. Gao G.F. MERS-CoV spike protein: targets for vaccines and therapeutics Antivir. Res. 133 2016 165 177 27468951 

  104. Wang W.L. Wang H.J. Deng Y. Song T. Lan J.M. Wu G.Z. Ke C.W. Tan W.J. Serological study of an imported case of Middle East respiratory syndrome and his close contacts in China, 2015 Biomed. Environ. Sci. 29 2016 219 223 27109133 

  105. Wang Y. Liu D. Shi W. Lu R. Wang W. Zhao Y. Deng Y. Zhou W. Ren H. Wu J. Wang Y. Wu G. Gao G.F. Tan W. Origin and possible genetic recombination of the Middle East respiratory syndrome coronavirus from the first imported case in China: phylogenetics and coalescence analysis mBio 6 2015 e01280?01215 

  106. Wang Y.D. Sin W.Y. Xu G.B. Yang H.H. Wong T.Y. Pang X.W. He X.Y. Zhang H.G. Ng J.N. Cheng C.S. Yu J. Meng L. Yang R.F. Lai S.T. Guo Z.H. Xie Y. Chen W.F. T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SARS J. Virol. 78 2004 5612 5618 15140958 

  107. Wong G. Liu W. Liu Y. Zhou B. Bi Y. Gao G.F. MERS, SARS, and Ebola: the role of super-spreaders in infectious disease Cell Host Microbe 18 2015 398 401 26468744 

  108. Woo P.C. Lau S.K. Wong B.H. Tsoi H.W. Fung A.M. Chan K.H. Tam V.K. Peiris J.S. Yuen K.Y. Detection of specific antibodies to severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein for serodiagnosis of SARS coronavirus pneumonia J.?Clin. Microbiol. 42 2004 2306 2309 15131220 

  109. Yang K. Sun K. Srinivasan K.N. Salmon J. Marques E.T. Xu J. August J.T. Immune responses to T-cell epitopes of SARS CoV-N protein are enhanced by N immunization with a chimera of lysosome-associated membrane protein Gene Ther. 16 2009 1353 1362 19727132 

  110. Yang L. Peng H. Zhu Z. Li G. Huang Z. Zhao Z. Koup R.A. Bailer R.T. Wu C. Persistent memory CD4+ and CD8+ T-cell responses in recovered severe acute respiratory syndrome (SARS) patients to SARS coronavirus M antigen J.?Gen. Virol. 88 2007 2740 2748 17872527 

  111. Yang L.T. Peng H. Zhu Z.L. Li G. Huang Z.T. Zhao Z.X. Koup R.A. Bailer R.T. Wu C.Y. Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients Clin. Immunol. 120 2006 171 178 16781892 

  112. Yang Y. Ye F. Zhu N. Wang W. Deng Y. Zhao Z. Tan W. Middle East respiratory syndrome coronavirus ORF4b protein inhibits type I interferon production through both cytoplasmic and nuclear targets Sci. Rep. 5 2015 17554 26631542 

  113. Zaki A.M. van Boheemen S. Bestebroer T.M. Osterhaus A.D. Fouchier R.A. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia New Engl. J. Med. 367 2012 1814 1820 23075143 

  114. Zhang N. Jiang S. Du L. Current advancements and potential strategies in the development of MERS-CoV vaccines Expert Rev. Vac. 13 2014 761 774 

  115. Zhang S. Bakshi R.K. Suneetha P.V. Fytili P. Antunes D.A. Vieira G.F. Jacobs R. Klade C.S. Manns M.P. Kraft A.R. Wedemeyer H. Schlaphoff V. Cornberg M. Frequency, private specificity, and cross-reactivity of preexisting hepatitis C virus (HCV)-Specific CD8+ T cells in HCV-seronegative individuals: implications for vaccine responses J.?Virol. 89 2015 8304 8317 26041301 

  116. Zhao J. Huang Q. Wang W. Zhang Y. Lv P. Gao X.M. Identification and characterization of dominant helper T-cell epitopes in the nucleocapsid protein of severe acute respiratory syndrome coronavirus J.?Virol. 81 2007 6079 6088 17392374 

  117. Zhao J. Perera R.A. Kayali G. Meyerholz D. Perlman S. Peiris M. Passive immunotherapy with dromedary immune serum in an experimental animal model for Middle East respiratory syndrome coronavirus infection J.?Virol. 89 2015 6117 6120 25787284 

  118. Zhao J. Zhao J. Mangalam A.K. Channappanavar R. Fett C. Meyerholz D.K. Agnihothram S. Baric R.S. David C.S. Perlman S. Airway memory CD4(+) T cells mediate protective immunity against emerging respiratory coronaviruses Immunity 44 2016 1379 1391 27287409 

  119. Zhao J. Zhao J. Perlman S. T?cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice J.?Virol. 84 2010 9318 9325 20610717 

  120. Zhao K. Wang H. Wu C. The immune responses of HLA-A*0201 restricted SARS-CoV S peptide-specific CD8(+) T cells are augmented in varying degrees by CpG ODN, PolyI: C and R848 Vaccine 29 2011 6670 6678 21745520 

  121. Zhao K. Yang B. Xu Y. Wu C. CD8+ T cell response in HLA-A*0201 transgenic mice is elicited by epitopes from SARS-CoV S protein Vaccine 28 2010 6666 6674 20709007 

  122. Zhi Y. Kobinger G.P. Jordan H. Suchma K. Weiss S.R. Shen H. Schumer G. Gao G. Boyer J.L. Crystal R.G. Wilson J.M. Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein Virology 335 2005 34 45 15823604 

  123. Zhou J. Chu H. Li C. Wong B.H. Cheng Z.S. Poon V.K. Sun T. Lau C.C. Wong K.K. Chan J.Y. Chan J.F. To K.K. Chan K.H. Zheng B.J. Yuen K.Y. Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis J.?Infect. Dis. 209 2014 1331 1342 24065148 

  124. Zhou M. Xu D. Li X. Li H. Shan M. Tang J. Wang M. Wang F.S. Zhu X. Tao H. He W. Tien P. Gao G.F. Screening and identification of severe acute respiratory syndrome-associated coronavirus-specific CTL epitopes J.?Immunol. 177 2006 2138 2145 16887973 

  125. Zhou T. Georgiev I. Wu X. Yang Z.Y. Dai K. Finzi A. Kwon Y.D. Scheid J.F. Shi W. Xu L. Yang Y. Zhu J. Nussenzweig M.C. Sodroski J. Shapiro L. Nabel G.J. Mascola J.R. Kwong P.D. Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01 Science 329 2010 811 817 20616231 

  126. Zust R. Cervantes-Barragan L. Kuri T. Blakqori G. Weber F. Ludewig B. Thiel V. Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines PLoS Pathog. 3 2007 e109 17696607 

관련 콘텐츠

오픈액세스(OA) 유형

BRONZE

출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문

이 논문과 함께 이용한 콘텐츠

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로